This inventor holds 7 USPTO granted patents and 6 published patent applications and 2 EPO patents. Top assignees: Aveo Pharmaceuticals, Inc., Pd-1 Acquisition Group, LLC, Osi Pharmaceuticals, Inc.. Active years: 2009-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- N. Reading, MA (US) (2009 - 2010)
- North Reading, MA (US) (2018)
- Newton, MA (US) (2017 - 2023)
Company Filing History:
4 out of 42 
3 out of 3 
1 out of 118 Years Active: 2009-2023
Title: The Innovations of Bin Feng: Pioneering Anti-PD-1 Antibodies
Introduction
Bin Feng, an accomplished inventor based in Newton, MA, has made significant contributions to the field of biotechnology. He holds a remarkable total of seven patents, showcasing his innovative spirit and dedication to scientific advancement. His work primarily focuses on the development of anti-PD-1 antibodies, which play a crucial role in cancer treatment.
Latest Patents
Among Bin Feng's notable inventions are his latest patents concerning anti-PD-1 antibodies. These antibodies are engineered to bind to programmed cell death protein 1 (PD-1), a pivotal protein involved in immune response regulation. His patents cover the compositions comprising these antibodies, along with methods for their production and potential therapeutic applications. This advancement represents a significant stride in immuno-oncology, offering new avenues for treating various cancers.
Career Highlights
Bin Feng's professional journey has seen him contribute his expertise to esteemed organizations such as Aveo Pharmaceuticals, Inc. and Pd-1 Acquisition Group, LLC. Through his work in these companies, he has played a vital role in pushing the boundaries of cancer therapeutics and has garnered recognition as a leading inventor in the field.
Collaborations
Throughout his career, Bin Feng has collaborated with several talented colleagues, including Maria Isabel Chiu and Najmia Amirina. These partnerships have facilitated the exchange of ideas and fostered innovation, allowing them to collectively advance research in cancer treatment and therapeutic antibody development.
Conclusion
Bin Feng's innovative contributions to the biotechnology sector, particularly in the realm of anti-PD-1 antibodies, underscore his commitment to improving patient outcomes in cancer care. With a growing portfolio of patents and collaborations with distinguished peers, he continues to be a significant figure in the ongoing fight against cancer. His work exemplifies the impact of dedicated inventors on public health and medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile